Ratika Kunder

PIM1 kinase inhibition as a targeted therapy against triple-negative breast tumors with elevated MYC expression

Dai Horiuchi, Roman Camarda, Alicia Y. Zhou et al. · Nature Medicine · 2016 · 167 citations

Medicine, Cancer Biology, Oncology +17

Distinctive microRNA signature of medulloblastomas associated with the WNT signaling pathway

Neelam Shirsat, Amit Gokhale, Ratika Kunder et al. · Journal of Cancer Research and Therapeutics · 2010 · 128 citations · Full text

Medicine, Genetics, Oncology +17

Real-time PCR assay based on the differential expression of microRNAs and protein-coding genes for molecular classification of formalin-fixed paraffin embedded medulloblastomas

Ratika Kunder, Rakesh Jalali, Sridhar Epari et al. · Neuro-Oncology · 2013 · 93 citations · Full text

Medicine, Oncology, Pathology +17

Downregulation of miR-204 expression defines a highly aggressive subset of Group 3/Group 4 medulloblastomas

Harish Shrikrishna Bharambe, Raikamal Paul, Pooja Panwalkar et al. · Acta Neuropathologica Communications · 2019 · 32 citations · Full text

Medicine, Cancer Biology, Oncology +17

Synergistic PIM kinase and proteasome inhibition as a therapeutic strategy for MYC-overexpressing triple-negative breast cancer

Ratika Kunder, Michelle Velyunskiy, Sara F. Dunne et al. · Cell chemical biology · 2021 · 22 citations · Full text

Medicine, Molecular Biology, Oncology +17